126 related articles for article (PubMed ID: 529256)
21. [Reynold's syndrome. A case report (author's transl)].
Alcocer J; Herrera R; Lavalle C; Gudiño J; Fraga A
Rev Gastroenterol Mex; 1978; 43(1):1-8. PubMed ID: 715342
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
[No Abstract] [Full Text] [Related]
23. Letter: Treatment of scleroderma.
Alarcón-Segovia D; Ibáñez G; Kershenobich D; Rojkind M
Lancet; 1974 May; 1(7865):1054-5. PubMed ID: 4133735
[No Abstract] [Full Text] [Related]
24. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis.
Fuchs D; Fruchter L; Fishel B; Holtzman M; Yaron M
Clin Rheumatol; 1986 Dec; 5(4):527-30. PubMed ID: 3816102
[TBL] [Abstract][Full Text] [Related]
25. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
26. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
28. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
29. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
Jimenez SA; Sigal SH
J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
[TBL] [Abstract][Full Text] [Related]
30. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report.
Palacio A; Hernández C; Marqués A; Prats J; Espinosa FJ
Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291
[TBL] [Abstract][Full Text] [Related]
31. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial.
Sais G; Vidaller A; Jucglà A; Gallardo F; Peyrí J
Arch Dermatol; 1995 Dec; 131(12):1399-402. PubMed ID: 7492128
[TBL] [Abstract][Full Text] [Related]
32. Failure of dimethyl sulfoxide in the treatment of scleroderma.
Binnick SA; Shore SS; Corman A; Fleischmajer R
Arch Dermatol; 1977 Oct; 113(10):1398-402. PubMed ID: 911168
[TBL] [Abstract][Full Text] [Related]
33. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
34. Global improvement of systemic scleroderma under long-term administration of octreotide.
Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
[TBL] [Abstract][Full Text] [Related]
35. Colchicine therapy in scleroderma. Preliminary results.
Frayha RA
Dermatologica; 1979; 159(1):78-81. PubMed ID: 478046
[No Abstract] [Full Text] [Related]
36. [Amyloidosis in children with rheumatoid arthritis and the results of its long-term treatment with colchicine].
Iandashevskaia SI; Iakovleva AA; Dvoriakovskaia GM; Sibiriakova LG
Ter Arkh; 1991; 63(12):100-5. PubMed ID: 1803583
[TBL] [Abstract][Full Text] [Related]
37. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
38. Colchicine use for familial Mediterranean fever. Observations associated with long-term treatment.
Peters RS; Lehman TJ; Schwabe AD
West J Med; 1983 Jan; 138(1):43-6. PubMed ID: 6837018
[TBL] [Abstract][Full Text] [Related]
39. Colchicine treatment of liver fibrosis.
Nikolaidis N; Kountouras J; Giouleme O; Tzarou V; Chatzizisi O; Patsiaoura K; Papageorgiou A; Leontsini M; Eugenidis N; Zamboulis C
Hepatogastroenterology; 2006; 53(68):281-5. PubMed ID: 16608040
[TBL] [Abstract][Full Text] [Related]
40. Improvement of progressive systemic sclerosis (PSS) with estriol treatment.
Katayama H; Ohsawa K; Yaoita H
Acta Derm Venereol; 1984; 64(2):168-71. PubMed ID: 6203310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
